CRISPR Therapeutics
CRSP
#3112
Rank
C$5.51 B
Marketcap
$64.63
Share price
-2.05%
Change (1 day)
-34.76%
Change (1 year)

CRISPR Therapeutics (CRSP) - Net assets

Net assets on the balance sheet as of September 2024 : C$2.70 Billion

According to CRISPR Therapeutics's latest financial reports the company has C$2.70 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

CRISPR Therapeutics - Net assets on balance sheet (from 2015 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$C$2.49 B-1.87%
2022-12-31$C$2.54 B-16.78%
2021-12-31$C$3.05 B44.11%
2020-12-31$C$2.12 B72.95%
2019-12-31$C$1.22 B129.66%
2018-12-31$C$0.53 B126.23%
2017-12-31$C$0.23 B-24.53%
2016-12-31$C$0.31 B-874.51%
2015-12-31$-C$40.41 Million399.2%
2014-12-31$-C$8.1 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$0.42 B-84.41%๐Ÿ‡บ๐Ÿ‡ธ USA